TLR9 and acute respiratory distress syndrome: On the other hand, TLR9 activation in the airways in mice using high dose CpG-motifs, does lead to inflammation in the airways, ARDS, and sepsis (Knuefermann et al., 2007; Schwartz et al., 1997).